Bringing medicine back to life?
→
What We Do.
We turn great ideas into accessible medicines. To do that we work with academics to turn their ideas into reality and in a societally responsible manner. For us, this means building a sustainable business while ensuring patient access. Explore our portfolio to see how we realize that ambition.
→
Reformulating For Cystinosis
Repurposing For PXE
Repurposing For VWM
Academic Partners.
Insights.
Planning for access – Socially Responsible Licensing
Orfenix welcomes a recently published report of the Medicines Patent Pool, in partnership with Boston Consulting Group, shows how voluntary licensing brings both improved access to medicines, in particular in low and middle-income countries and economic benefits to the companies doing the out-licensing.
Orfenix takes the next steps
Orfenix is proud to announce that Ivo de Nooijer has formally joined Orfenix as a shareholder and partner as of 1 July 2024.
Bringing Medicine Back To Life
Vincent van der Wel founded Orfenix to bridge gaps in the pharmaceutical industry, uniting stakeholders to develop affordable and profitable remedies for patients.
Contact Orfenix.
For more information or to explore partnership opportunities, feel free to reach out to us anytime!
→
→ Follow us on LinkedIn
→ Meet the team